For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Biogen Ma Inc.

USPTO Granted Patents = 268

% Expired Patents = 11.9

CIPO Patents = 23

EPO Patents = 144

Trademarks = 37

Forward Citations = 987

Loading Chart...

Loading Chart...

444 inventors (with patents filed for the assignee):

Bin Ma (35 out of 39 patents)

Gnanasambandam Kumaravel (33 out of 60 patents)

Kevin Guckian (31 out of 41 patents)

4. Brian T Hopkins (25 out of 35 patents)

5. Zhili Xin (21 out of 44 patents)

6. Lei Zhang (18 out of 22 patents)

7. Sha Mi (16 out of 34 patents)

8. Timothy Raymond Chan (15 out of 18 patents)

9. Meena Subramanyam (14 out of 16 patents)

10. Tatiana Plavina (14 out of 14 patents)

11. Jermaine Thomas (14 out of 21 patents)

12. Edward Yin-Shiang Lin (13 out of 22 patents)

13. Tracy J Jenkins (13 out of 19 patents)

14. Arthur G Taveras (13 out of 72 patents)

15. Joseph P Lyssikatos (12 out of 141 patents)

Core Competencies:

Autoimmune Diseases

Bruton's Tyrosine Kinase

Glycosylation Control

O-glycoprotein Inhibitors

Raman Spectroscopy

Alzheimer's Treatment

Neurofilament Protein

Drug Delivery

Cerebral Hemorrhage

Inflammation Treatment

SMN Protein

Biaryl Inhibitors

268 patents: Sort by Forward Citations

1. 12747241 - Compounds for targeting degradation of Bruton's tyrosine kinase (2026-09-29),

2. 12734236 - ANTI-VLA-4 ANTIBODIES (2026-09-15),

3. 12716899 - Methods for determining differences in alpha-4 integrin activity by correlating differences in sVCAM and/or sMAdCAM levels (2026-08-25),

4. 12709621 - TYK2 INHIBITORS (2026-08-18),

5. 12692495 - Methods of preparing oligonucleotide compositions using ultrafiltration/diafiltration (2026-07-28),

6. 12685851 - Fluid catheter device for recording brain state (2026-07-21),

7. 12679882 - OPTIMIZED FACTOR VIII GENE (2026-07-14),

8. 12656353 - BIOMARKERS OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (2026-06-16),

9. 12607638 - Methods of treating inflammatory and autoimmune diseases with natalizumab (2026-04-21),

10. 12605537 - Implantable medical device for use with or having recording electrode (2026-04-21),

11. 12570691 - PURIFICATION OF CHIMERIC FVIII MOLECULES (2026-03-10),

12. 12570631 - Substituted N-(4-(pyrimidin and pyridin-4-yl)benzylcarboxamides and its use for treating disorders responsive to inhibition of Btk (2026-03-10),

13. 12565504 - Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors (2026-03-03),

14. 12565500 - Substituted pyrrolo[1,2-b]pyridazines and pyrrolo[2,1-f][1,2,4]triazines as Btk inhibitors (2026-03-03),

15. 12551669 - Medical system including two access ports (2026-02-17),

Company Overview

Biogen Ma Inc., headquartered in Cambridge, MA, is a leader in biotechnology focused on developing therapies for neurological and autoimmune diseases. The company specializes in innovative treatments targeting conditions such as Alzheimer's disease and employs advanced technologies including Bruton's Tyrosine Kinase inhibitors and glycosylation control methods. Biogen's research also encompasses drug delivery systems and the application of Raman spectroscopy, positioning it at the forefront of medical advancements in neurodegenerative disorders.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

268 Patents

#13 in Cambridge, MA

#97 in Massachusetts

#1,621 in US

#3,274 in the World

Cambridge, MA, United States of America

Biogen Ma Inc.

Forward Citations = 987

444 inventors:

Bin Ma (35 out of 39 patents)

Gnanasambandam Kumaravel (33 out of 60 patents)

Kevin Guckian (31 out of 41 patents)

4. Brian T Hopkins (25 out of 35 patents)

5. Zhili Xin (21 out of 44 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biogen Ma Inc.. Retrieved from https://idiyas.com/company/biogen-ma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…